5G3 — TalkMed Balance Sheet
0.000.00%
HealthcareBalancedMid Cap
- SG$609.05m
- SG$527.48m
- SG$78.18m
Annual balance sheet for TalkMed, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 79.4 | 82.2 | 81.2 | 89.9 | 82.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10.3 | 9 | 11.8 | 11.4 | 13.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 91.3 | 92.4 | 94.8 | 103 | 97.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6.17 | 8.51 | 10.1 | 9.66 | 8.72 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 105 | 109 | 109 | 116 | 107 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17.4 | 14.2 | 19.4 | 27.3 | 26.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 21.2 | 18.6 | 20.5 | 25.7 | 22.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 83.4 | 90.2 | 88.7 | 90.1 | 84 |
| Total Liabilities & Shareholders' Equity | 105 | 109 | 109 | 116 | 107 |
| Total Common Shares Outstanding |